TENAYA THERAPEUTICS INC
NASDAQ: TNYA (Tenaya Therapeutics, Inc.)
Kemas kini terakhir: semalam, 3:08AM0.679
0.01 (1.06%)
| Penutupan Terdahulu | 0.672 |
| Jumlah Dagangan | 4,853,683 |
| Harga / Jualan (P/S) | 97.15 |
| Harga / Buku (P/B) | 2.17 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -1.15 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.81% |
| Nisbah Semasa (MRQ) | 6.68 |
| Aliran Tunai Operasi (OCF TTM) | -84.95 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -48.05 M |
| Pulangan Atas Aset (ROA TTM) | -41.71% |
| Pulangan Atas Ekuiti (ROE TTM) | -76.21% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Tenaya Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.5 |
| Purata | -0.13 |
|
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.72% |
| % Dimiliki oleh Institusi | 59.67% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Burkehill Global Management, Lp | 30 Jun 2026 | 2,000,000 |
| Raiffeisen Bank International Ag | 30 Jun 2026 | 1,200,000 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ALI FARAZ | 0.649 | - | 122,000 | 79,178 |
| TINGLEY WHITTEMORE | 0.649 | - | 49,000 | 31,801 |
| Jumlah Keseluruhan Kuantiti Bersih | 171,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 110,979 | |||
| Purata Pembelian Keseluruhan ($) | 0.649 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| TINGLEY WHITTEMORE | Pegawai | 10 Sep 2026 | Diperolehi (+) | 49,000 | 0.649 | 31,801 |
| ALI FARAZ | Pegawai | 10 Sep 2026 | Diperolehi (+) | 122,000 | 0.649 | 79,178 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |